Carnitine Metabolism in Chronic Liver Disease
Overview
Biology
Physiology
Authors
Affiliations
The liver is a central organ for carnitine metabolism and for the distribution of carnitine to the body. It is therefore not surprising that carnitine metabolism is impaired in patients and experimental animals with certain types of chronic liver disease. In this review, the changes in carnitine metabolism associated with chronic liver disease and the role of carnitine as a therapeutic agent in some of these conditions are discussed.
The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions.
Ugonabo O, Udoh U, Rajan P, Reeves H, Arcand C, Nakafuku Y Biomolecules. 2023; 13(9).
PMID: 37759769 PMC: 10526956. DOI: 10.3390/biom13091369.
Abbasnezhad A, Hasanavand A, Falahi E, Kashkooli S, Asbaghi O, Choghakhori R Prev Nutr Food Sci. 2020; 25(2):124-132.
PMID: 32676462 PMC: 7333001. DOI: 10.3746/pnf.2020.25.2.124.
Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis.
Hanai T, Shiraki M, Imai K, Suetugu A, Takai K, Shimizu M Nutrients. 2020; 12(7).
PMID: 32610446 PMC: 7401279. DOI: 10.3390/nu12071915.
Acetyl-L-carnitine for patients with hepatic encephalopathy.
Marti-Carvajal A, Gluud C, Arevalo-Rodriguez I, Marti-Amarista C Cochrane Database Syst Rev. 2019; 1:CD011451.
PMID: 30610762 PMC: 6353234. DOI: 10.1002/14651858.CD011451.pub2.
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
Kimhofer T, Fye H, Taylor-Robinson S, Thursz M, Holmes E Br J Cancer. 2015; 112(7):1141-56.
PMID: 25826224 PMC: 4385954. DOI: 10.1038/bjc.2015.38.